Trial Profile
A Double-blind, Randomised, Placebo-controlled Study to Evaluate the Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Dose Regimens of Etamicastat (BIA 5-453) in Hypertensive Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Apr 2017
Price :
$35
*
At a glance
- Drugs Etamicastat (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Bial
- 07 Apr 2017 New trial record